Genomic RNA from the human prototype strain H of the hepatitis C virus (HCV-H) has been molecularly cloned and sequenced. The HCV-H sequence reported consists of 9416 nucleotides including the 5' and 3' untranslated regions. HCV-H shows 96% amino acid identity with the American isolate HCV-1 but only 84.9% with the Japanese isolates HCV-J and HCV-BK. In addition to the hypervariable region (region V) previously identified in the putative E2 domain, three other variable domains were identified: region V1 (putative El), region V2 (putative E2), and region V3 (putative NS5). These regions appear rather conserved (86-100%) among the American isolates (HCV-1 and HC-J1) or among various Japanese isolates (HCV-J, HCV-BK, HCV-JH, and HC-J4) but show striking heterogeneity when the two subgroups are compared (42-87.5% amino acid difference). A structural similarity between the 5'-terminal hairpin structure of HCV and of poliovirus was observed. This study further suggests the existence of at least two genomic subtypes of HCV and confirms a distant relationship between HCV and pestiviruses.
Following the introduction of diagnostic methods to detect hepatitis B virus and hepatitis A virus, it was demonstrated that a third class of infectious agents referred to as non-A, non-B (NANB) hepatitis virus was responsible for 60-90% of posttransfusion NANB hepatitis (1) (2) (3) . A predominant agent of NANB hepatitis has recently been identified and termed hepatitis C virus (HCV) (4) . Expression of a HCV cDNA clone in yeast led to the development of assays that detect HCV antibodies in a high proportion of serum samples from patients with chronic NANB hepatitis (5) (6) (7) . These data suggest that HCV causes most if not all blood-borne NANB hepatitis.
Isolation of HCV cDNA clones has been reported by a number of researchers in the United States and in Japan (4, (8) (9) (10) (11) . In addition, the cloning and complete genomic sequence of three distinct HCV isolates, one American and two Japanese (HCV-1, HCV-J, and HCV-BK), has been reported (12) (13) (14) . These studies indicate that HCV is a positive-strand RNA virus with a genome size of -10 kilobases [9401-9416 nucleotides (nt)] encoding a single continuous translational open reading frame [3010-3011 amino acid (aa) residues]. Analysis of the three HCV genomic sequences reveals homologies at the nucleotide sequence, amino acid sequence, and hydropathicity-plot levels with the nonstructural (NS) proteins of the flaviviruses, as well as with animal pestiviruses and some plant viruses (15) . Preliminary sequence comparisons using the existing data base indicate that the HCV family is a rather heterologous family of viruses (85-%% homology), exhibiting domains of great variability, in particular in the putative envelope region (16) . The American HCV prototype strain H (HCV-H) originally obtained from a patient with chronic posttransfusion NANB hepatitis (17) was isolated by inoculation in chimpanzees in 1979 (18) and has been used to carry out numerous experiments in the chimpanzee model. We decided to clone the genome of HCV-H in order to provide basic information that would help to better interpret data accumulated using this isolate. In this article, we report the complete nucleotide sequence of the genomic RNA of HCV-H and compare this with genomic sequences of the other reported HCV isolates.l Nucleic acids were extracted from liver and plasma as described (20) (21) (22) .
MATERIALS AND METHODS
Cloning of HCV cDNA. Procedures for cDNA synthesis have been described in detail (21, 22) . Specific oligonucleotide primers derived from published HCV sequences (10, 12, 23, 24) were used to prime the reaction. Selected target sequences were amplified by a PCR-based approach using a variety of oligonucleotide primers as mentioned above. Conditions for amplification were as described (21) . Amplified sequences were subsequently isolated, blunt-ended, and inserted into pUC18 or pBluescript (Stratagene) cloning vectors by standard procedures (20) .
Sequence Analysis of Cloned cDNA. Clones were sequenced by the dideoxy chain-termination method (25) between 124 and 615 nt. The putative map location of these clones is shown in Fig. 1 . The sequence of the HCV-H genome was deduced, representing 9416 nt, which is similar in length to that of previously isolated HCV genomes. The sequence has a high G+C content (58.8%) and contains one large open reading frame (nt 1-9033) corresponding to a polyprotein of 3011 aa.
Sequences comprising segments form the 5' and 3' ends of the viral genome (nt 1-359 and 9120-9416) are shown in Fig.  2 A and B, respectively. We were able to identify HCV-H sequences from the 5' and 3' noncoding domains, comprising 341 and 42 nt, respectively. The first 12 nt and the last 20 nt (Fig. 2 A and B, shaded boxes) correspond to the nucleotide primers used in the amplification process and thus are not confirmed as HCV-H sequences. We could not obtain viral sequences when we used an oligo(dT) primer for cDNA synthesis followed by PCR amplification using different combinations of primers, suggesting the absence of internal A-rich tracts at the 3'-terminal end or of a 3'-terminal poly(A) sequence. Similarly, no sequences could be amplified when A-rich primers complementary to the 3'-end (U-rich) nucleotide sequence of the two reported Japanese isolates HCV-J and HCV-BK were used in the cDNA priming reaction, suggesting the absence of a U-rich terminal sequence in the genome of HCV-H. A small hairpin structure could be assigned at the 3' terminus (bottom of We identified, as described in previous reports for other HCV isolates, that the HCV-H genome or polyprotein shares only limited similarity with other known viral sequences, except for three domains: (i) a few stretches of nucleotides in the 5' noncoding region identical to those reported for the American prototype HCV-1 (13, 23) that correspond to conserved elements in pestiviruses ( Fig American isolates (data not shown) but only 12.5% identical when compared with Japanese isolates (Fig. 3D) . Most (Fig. 3B) , we identified two regions of high variability. Both regions, which we have termed regions V1 and V2 (aa 246-275 and 456-482, respectively) appeared very conserved among American or Japanese HCV (86-96% identity) but showed much greater heterogeneity when the two groups were compared (55-58% identity; Fig. 3 A and C).
DISCUSSION
The human prototype strain H of HCV (HCV-H) was one of the originally identified isolates of the virus (18) . We report here the cDNA sequence of HCV-H (9416 nt). To date, this is the second nucleotide sequence of a HCV genome determined for a single prototype strain, as the two other sequenced Japanese strains, HCV-J and HCV-BK (12, 14) , were derived from clones isolated from pooled plasma and may therefore represent genomic sequences from diverse isolates.
The genome of HCV-H shows an overall amino acid identity of 96% with the American prototype HCV-1 and 84.9o with both HCV-J and HCV-BK isolates. Three new regions of high variability were identified within El, E2, and NS5 (regions V1, V2, and V3). In these regions, sequence heterogeneity appears to be subgroup-specific (i.e., American vs. Japanese isolates), in particular for region V3, where up to 87.5% divergence was found between the two subgroups. Sequence heterogeneity has been observed in the envelope/NS1 regions of flaviviruses but not to the extent reported here for regions V1 and V2. That three of four variable regions within the HCV genome are located in the putative envelope domains suggests that these domains might be under immunological pressure. It remains to be determined whether the putative El and E2/NS1 regions of HCV are immunogenic and whether they can elicit protective immunity as seen with envelopes of pestiviruses (29, 30) or flaviviruses (31, 32) . Possibly, the heterogeneity found at the structural level in these domains as well as within the NS5 domain in region V3 may also reflect antigenic heterogeneity among different HCV isolates.
Ogata et al. (19) recently published partial sequence of the original HCV-H strain directly isolated from patient H in 1977 and prior to transmission to chimpanzee. Comparison with the HCV-H sequence obtained in our study indicates 98.5% identity in the structural domain (aa 1-778), 98.8% identity in the NS3 domain (aa 1209-1636), and 98.8% identity in the NS5 domain (aa 2530-2869). The greatest rate of divergence between the two isolates was found in the hypervariable region V, with 2.5% nucleotide and 6.8% amino acid difference respectively, whereas 100lo identity was observed in both regions V1 and V2 (region V3 was not available for Proc. Natl. Acad. Sci. USA 88 (1991) Table 1 comparison). The high rate of divergence found in region V, generated after a single passage in chimpanzee, confirms the ability of the HCV genome to evolve very rapidly in this specific genomic domain.
We report at least two repeated sequences (R2 and R3) that appear to be conserved among all HCV isolates and may thus represent regulatory elements important for the replication process. The repeated sequence R2 is particularly interesting because it has the highest copy number (four), is found within both the 5'-and 3'-terminal ends, and is found immediately upstream from the 3'-terminal hairpin loop (Fig. 2B) . A similar type of extremely conserved sequence, found directly upstream from the 3'-terminal hairpin structure of flavivirus genomes, was suggested to be related to the cyclization of these viruses (33) . Nothing is known about putative cyclization of HCVs.
Despite geographical separation, different HCV isolates displayed nearly complete identity in the 5' noncoding region.
A similar observation has been made in flaviviruses that are members of the same serologically related subgroup (34) , whereas members of different antigenic subgroups share only low levels of homology in that region. This is in contrast to what has been reported for polioviruses, for which sequence conservation is very high in the 5' noncoding region of different serotypes (35) . Antigenic grouping of HCV isolates remains to be determined.
No poly(A) sequences were identified in this study, in contrast to the report by Han et al. (23) . Attempts to identify subgenomic poly(A)+ RNA species for HCV-H also failed. We cannot exclude the possibility that our starting material (liver tissue or plasma) may not have contained all forms of viral RNA, although this seems unlikely. None of the HCV genomes so far reported contain the AAUAAA motif in the 3'-terminal noncoding sequence that has been implicated as polyadenylylation signal for cellular mRNA (36) , although poly(A) tails could be genetically coded. The HCV-H 3'-terminal sequence seems to be more closely related to the structure of Japanese HCV isolates, but because of the complex secondary structure of the HCV 3' terminus these results may not be definitive.
The 5' hairpin structure originally described by Han et al. (23) for HCV-1 has been also identified for HCV-H (nt -341 to -319). No hairpin loops have been reported at the 5' end of pestivirus genomes, possibly because the authentic 5'-terminal sequence of these viruses has not been cloned. By contrast, highly conserved hairpin structures have been located at the 5' end of viral RNA from enteroviruses, rhinoviruses, and picornaviruses. These structures have been implicated in translational control and efficient viral replication. Recently, Simoer and Sarnow (37) demonstrated that the 5'-proximal RNA hairpin may play a major role in the life cycle of poliovirus, since infectious cDNA clones mutated in that region were replication-deficient. We found that the HCV 5' hairpin structure displays an interesting degree of homology (in terms of nucleotide sequence and configuration) with the structure described by those authors (Fig. 4) . The homology observed here suggests that this sequence may represent the authentic 5' end of the HCV genome. Based on the original observation by Kato et al. (12) [i.e., the short length of the 3' noncoding region of HCV (54 nt) and the presence of a poly(U) stretch at the 3' end] and our observation concerning the 5' hairpin structure, HCV appears to show interesting homologies with both terminal ends of polioviruses. In addition, as for HCV, a high number of unused AUG codons (up to eight) preceding the initial start codon have also been identified in the 5' noncoding region of polioviruses (38, 39) . Thus HCVs may share some structural and possibly functional similarities with polioviruses with respect to cis-acting elements involved in the control of viral replication. Clearly, there is a need for an in vitro tissue culture system and/or the development of HCV infectious cDNA clones to allow further exploration of this hypothesis.
In conclusion, our data confirm the existence of at least two distinct genomic subtypes of HCV (i.e., American-and Japanese-type isolates) and suggest a similarity between structural and functional elements implicated in the regulation of viral replication for HCV, pestiviruses, and polioviruses.
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